id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0322-0011,FDA,FDA-2009-D-0322,Guidance for Industry Dosage Delivery Devices for Orally Ingested OTC Liquid Drug Products; Availability,Notice,NAD-Notice of Availability of Data,2011-05-05T04:00:00Z,2011,5,2011-05-05T04:00:00Z,,2011-05-05T12:30:39Z,2011-10965,0,0,0900006480c3fc4e
FDA-2009-D-0322-0012,FDA,FDA-2009-D-0322,Guidance for Industry;  Dosage Delivery Devices for Orally Ingested OTC Liquid Drug Products,Other,Guidance,2011-05-05T04:00:00Z,2011,5,2011-05-05T04:00:00Z,,2024-11-12T04:57:42Z,,1,0,0900006480c3f4a1
FDA-2009-D-0322-0002,FDA,FDA-2009-D-0322,Guidance for Industry Dosage Delivery Devices for OTC Liquid Drug Products,Other,GDL-Guidance (Supporting and Related Materials),2009-11-05T05:00:00Z,2009,11,2009-11-05T05:00:00Z,2010-02-04T04:59:59Z,2009-11-05T15:27:38Z,,0,0,0900006480a5216a
FDA-2009-D-0322-0001,FDA,FDA-2009-D-0322,Draft Guidance for Industry on Dosage Delivery Devices for Over-The-Counter Liquid Drug Products; Availability,Notice,NAD-Notice of Availability of Data,2009-11-05T05:00:00Z,2009,11,2009-11-05T05:00:00Z,2010-02-04T04:59:59Z,2009-11-05T15:22:21Z,E9-26531,0,0,0900006480a5173f